Serge J E Lebecque

Title: The Innovations of Serge J E Lebecque

Introduction

Serge J E Lebecque is a notable inventor based in Civrieux d'Azergue, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and related diagnostic methods. With a total of 13 patents to his name, his work has had a considerable impact on medical research and applications.

Latest Patents

Among his latest patents, one focuses on monoclonal antibodies to human CTLA-8 (IL-17A). This patent includes the human CTLA-8 protein, antibodies that specifically bind to human CTLA-8, and nucleic acids encoding human CTLA-8. Additionally, methods of using these molecules and diagnostic kits are provided. Another significant patent involves isolated mammalian membrane proteins and related agents. This patent describes nucleic acids encoding various lymphocyte cell proteins from mammals, including primates, along with specific antibodies and purified proteins. Methods of using these reagents and related diagnostic kits are also included.

Career Highlights

Throughout his career, Serge has worked with prominent organizations, including Schering Corporation. His innovative work has contributed to advancements in therapeutic and diagnostic technologies, showcasing his expertise in the field.

Collaborations

Serge has collaborated with notable individuals such as Jenny Valladeau and Elizabeth Esther Mary Bates. These partnerships have further enhanced the scope and impact of his research.

Conclusion

Serge J E Lebecque's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence medical research and applications, paving the way for future innovations.